about
Interleukin-32δ interacts with IL-32β and inhibits IL-32β-mediated IL-10 productionA cytokine-centric view of the pathogenesis and treatment of autoimmune arthritisOncostatin M Enhances the Antiviral Effects of Type I Interferon and Activates Immunostimulatory Functions in Liver Epithelial CellsInterleukin-32 expression in the pancreasInterleukin 32 (IL-32) contains a typical α-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1.Gene expression profiling in limb-girdle muscular dystrophy 2AAnalysis of FOXP3+ regulatory T cells that display apparent viral antigen specificity during chronic hepatitis C virus infection.IL-32 promotes angiogenesis.Real-imaging cDNA-AFLP transcript profiling of pancreatic cancer patients: Egr-1 as a potential key regulator of muscle cachexiaChungsim-Yeunja-Tang decreases the inflammatory response in peripheral blood mononuclear cells from patients with cerebral infarction through an NF-κB dependent mechanismCytokine-modulating strategies and newer cytokine targets for arthritis therapy.The immunosuppressive role of IL-32 in lymphatic tissue during HIV-1 infectionElevated interleukin-32 expression is associated with Helicobacter pylori-related gastritis.IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals.IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease.Association between IL-32 genotypes and outcome in infection-associated acute lung injury.Differential expression of interleukin-32 in chronic rhinosinusitis with and without nasal polypsMaintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver FailureSoluble interleukin-6 receptor is elevated during influenza A virus infection and mediates the IL-6 and IL-32 inflammatory cytokine burst.The Role of Cathelicidin LL-37 in Cancer Development.Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK functionDecreased severity of collagen antibody and lipopolysaccharide-induced arthritis in human IL-32β overexpressed transgenic mice.The expression of interleukin-32 is activated by human cytomegalovirus infection and down regulated by hcmv-miR-UL112-1Neutrophil serine proteases fine-tune the inflammatory responseIL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritisIL-32-dependent effects of IL-1beta on endothelial cell functionsMucosal cytokine network in inflammatory bowel disease.The biological and clinical importance of the 'new generation' cytokines in rheumatic diseasesInterleukin-32 Gamma Stimulates Bone Formation by Increasing miR-29a in Osteoblastic Cells and Prevents the Development of Osteoporosis.Role of interleukin-32 in chronic rhinosinusitisIL-32α-induced inflammation constitutes a link between obesity and colon cancer.A panoramic spectrum of complex interplay between the immune system and IL-32 during pathogenesis of various systemic infections and inflammation.Interleukin-32 enhances cytotoxic effect of natural killer cells to cancer cells via activation of death receptor 3.Evidence that TNF-β (lymphotoxin α) can activate the inflammatory environment in human chondrocytes.IL-32α has differential effects on proliferation and apoptosis of human melanoma cell lines.Determination of differentially regulated proteins upon proteasome inhibition in AML cell lines by the combination of large-scale and targeted quantitative proteomics.Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene.A proinflammatory cytokine interleukin-32beta promotes the production of an anti-inflammatory cytokine interleukin-10.Differential expression of immunoregulatory genes in monocytes in response to Porphyromonas gingivalis and Escherichia coli lipopolysaccharide.
P2860
Q24317887-8BBC739A-C2D1-4EFE-8D75-2A6DFABE30C7Q26823326-2EA19035-EDF8-4C61-9B95-032FF7DEA78BQ27488206-E64D1998-1422-4333-8C34-CF0B2E2200C9Q28390023-DBC11F56-C092-4CD4-BE2A-A7E9FAC426D9Q30411120-8878F52A-927F-48DD-86A5-3CDAF7A74F63Q33385149-ADFCA63C-8F2D-4A36-B73D-AB11F959585DQ33521313-D9BC09CD-8FEA-425B-B526-814F1C45DEFBQ33555523-49B76359-5626-4B48-8E20-C64E7785A916Q34312903-A6571FF8-EED6-4145-B522-B6B49389AF38Q34437388-F934FC48-F6CB-498C-A5ED-4FD87A4C3E1AQ34456715-5F6B6BB3-3AAB-4F03-9EB7-8A34501DA022Q34995534-E568DD69-17D7-4E7E-B67A-8F93E08A1BF4Q35122065-FC6926CF-ACE8-493C-9BDC-3474CD770DFDQ35134651-CEDD96C6-B436-4C5E-9BDF-358D59156800Q35469357-FCCA4EFC-F7E0-4209-96A6-CA38E062D71DQ35558297-B649BD7F-6944-47E5-8C7C-93C2EE011016Q35605921-D17B2FC9-D662-4B76-B6CE-8EBE9BAF1D6EQ35641151-64B635A3-25F5-4623-92DF-2E9696AD4625Q35737498-AE494E7C-E56A-461B-B58C-7267143F587CQ36085075-DAD7EE80-3E5F-4695-87B8-FC864E6839EEQ36465085-CF4AB19D-BF7C-4E40-B159-C2511CDFD9FAQ36498379-49115699-6E34-4E30-A5FE-20A3213C680BQ36629365-62F958D5-6E09-4D60-B859-D4700CF1A14DQ36686444-E99868E1-BF9A-4E40-8D64-3A7A6917FF81Q36737987-E2D5D144-67E6-42E9-827B-06E869C4165AQ36907602-CABD210C-8D91-40DD-945E-99E28890B2D2Q37129422-A50DDEBD-DD88-4A6F-96A2-1EAAA7C32806Q37263008-BDB2786E-8577-4A3D-85BC-328453911302Q37516563-FA8E0249-D365-4A46-8CBE-82A7868707CFQ37581596-B9C83E59-0CD2-487B-9A8C-36CF8313146AQ38067583-C6B43320-E492-49E7-BFA2-15219DEE6642Q38287509-1EC4B05C-9C20-4296-80D7-884338054592Q38334454-53C372DE-4D7F-451D-8A04-0161BDFAA588Q38469030-1D49B6F7-8A60-41FA-979B-DCBDC7D7E8DEQ38651509-A5E90F4F-B772-490E-82E7-E569BFCAD5DAQ38776515-0F770FB0-FB7E-4D53-BF24-B70E59260722Q39317321-4684DC86-FE7C-4DEC-B3D2-F4F95669DB49Q39611935-E9676519-0540-4084-81C6-2A25E9D1C842Q39796190-45C7531F-A992-45E8-820F-DED1EB6FBEABQ39852234-201E6DDB-3099-4FEF-B700-53CA2E5A363D
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
IL-32, a novel cytokine with a possible role in disease
@ast
IL-32, a novel cytokine with a possible role in disease
@en
type
label
IL-32, a novel cytokine with a possible role in disease
@ast
IL-32, a novel cytokine with a possible role in disease
@en
prefLabel
IL-32, a novel cytokine with a possible role in disease
@ast
IL-32, a novel cytokine with a possible role in disease
@en
P2860
P356
P1476
IL-32, a novel cytokine with a possible role in disease
@en
P2093
C A Dinarello
P2860
P304
P356
10.1136/ARD.2006.058511
P407
P478
65 Suppl 3
P577
2006-11-01T00:00:00Z